Abstract
The pro-opiomelanocortin (POMC)-expressing neurons of the hypothalamic arcuate nucleus (ARC) are involved in the control of food intake and metabolic processes. It is assumed that, in addition to leptin, the activity of these neurons is regulated by serotonin and dopamine, but only subtype 2C serotonin receptors (5-HT2CR) was identified earlier on the POMC-neurons. The aim of this work was a comparative study of the localization and number of leptin receptors (LepR), types 1 and 2 dopamine receptors (D1R, D2R), 5-HT1BR and 5-HT2CR on the POMC-neurons and the expression of the genes encoding them in the ARC of the normal and diet-induced obese (DIO) rodents and the agouti mice (Ay/a) with the melanocortin obesity. As shown by immunohistochemistry (IHC), all the studied receptors were located on the POMC-immunopositive neurons, and their IHC-content was in agreement with the expression of their genes. In DIO rats the number of D1R and D2R in the POMC-neurons and their expression in the ARC were reduced. In DIO mice the number of D1R and D2R did not change, while the number of LepR and 5-HT2CR was increased, although to a small extent. In the POMC-neurons of agouti mice the number of LepR, D2R, 5-HT1BR and 5-HT2CR was increased, and the D1R number was reduced. Thus, our data demonstrates for the first time the localization of different types of the serotonin and dopamine receptors on the POMC-neurons and a specific pattern of the changes of their number and expression in the DIO and melanocortin obesity.
Similar content being viewed by others
References
Nogueiras R, Wiedmer P, Perez-Tilve D, Veyrat-Durebex C, Keogh JM, Sutton GM, Pfluger PT, Castaneda TR, Neschen S, Hofmann SM et al (2007) The central melanocortin system directly controls peripheral lipid metabolism. J Clin Invest 117(11):3475–3488. https://doi.org/10.1172/JCI31743
Begriche K, Girardet C, McDonald P, Butler AA (2013) Melanocortin-3 receptors and metabolic homeostasis. Prog Mol Biol Transl Sci 114:109–146. https://doi.org/10.1016/B978-0-12-386933-3.00004-2
Girardet C, Butler AA (2014) Neural melanocortin receptors in obesity and related metabolic disorders. Biochim Biophys Acta 1842(3):482–494. https://doi.org/10.1016/j.bbadis.2013.05.004
Pandit R, Omrani A, Luijendijk MC, de Vrind VA, Van Rozen AJ, Ophuis RJ, Garner K, Kallo I, Ghanem A, Liposits Z et al (2016) Melanocortin 3 receptor signaling in midbrain dopamine neurons increases the motivation for food reward. Neuropsychopharmacology 41(9):2241–2251. https://doi.org/10.1038/npp.2016.19
Hahn TM, Breininger JF, Baskin DG, Shwartz MW (1998) Coexpression of AgRp and NPY in fasting-activated hypothalamic neurons. Nat Neurosci 1:271–272. https://doi.org/10.1038/1082
Roseberry AG, Stuhrman K, Dunigan AI (2015) Regulation of the mesocorticolimbic and mesostriatal dopamine systems by α-melanocyte stimulating hormone and agouti-related protein. Neurosci Biobehav Rev 56:15–25. https://doi.org/10.1016/j.neubiorev.2015.06.020
Sohn JW (2015) Network of hypothalamic neurons that control appetite. BMB Rep 48(4):229–233. https://doi.org/10.5483/BMBRep.2015.48.4.272
Boswell T, Dunn IC (2017) Regulation of agouti-related protein and pro-opiomelanocortin gene expression in the avian arcuate nucleus. Front Endocrinol 8:75. https://doi.org/10.3389/fendo.2017.00075
Varela L, Horvath TL (2012) Leptin and insulin pathways in POMC and AgRP neurons that modulate energy balance and glucose homeostasis. EMBO Rep 13(12):1079–1086. https://doi.org/10.1038/embor.2012.174
Lima LB, Metzger M, Furigo IC, Donato J Jr (2016) Leptin receptor-positive and leptin receptor-negative proopiomelanocortin neurons innervate an identical set of brain structures. Brain Res 1646:366–376. https://doi.org/10.1016/j.brainres.2016.06.024
Ha S, Baver S, Huo L, Gata A, Hairston J, Huntoon N, Li W, Zhang T, Benecchi EJ, Ericsson M, Hentges ST, Bjørbæk C (2013) Somato-dendritic localization and signaling by leptin receptors in hypothalamic POMC and AgRP neurons. PLoS ONE 8(10):e77622. https://doi.org/10.1371/journal.pone.0077622
Derghal A, Djelloul M, Airault C, Pierre C, Dallaporta M, Troadec JD, Tillement V, Tardivel C, Bariohay B, Trouslard J, Mounien L (2015) Leptin is required for hypothalamic regulation of miRNAs targeting POMC 3′UTR. Front Cell Neurosci 9:172. https://doi.org/10.3389/fncel.2015.00172
Ghamari-Langroudi M, Srisai D, Cone RD (2011) Multinodal regulation of the arcuate/paraventricular nucleus circuit by leptin. Proc Natl Acad Sci USA 108(1):355–360. https://doi.org/10.1073/pnas.1016785108
Tecott LH (2007) Serotonin and the orchestration of energy balance. Cell Metab 6:352–361. https://doi.org/10.1016/j.cmet.2007.09.012
Volkow ND, Wang GJ, Baler RD (2011) Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn Sci 15:37–46. https://doi.org/10.1016/j.tics.2010.11.001
Martin-Gronert MS, Stocker CJ, Wargent ET, Cripps RL, Garfield AS, Jovanovic Z, D’Agostino G, Yeo GS, Cawthorne MA, Arch JR, Heisler LK, Ozanne SE (2016) 5-HT2A and 5-HT2C receptors as hypothalamic targets of developmental programming in male rats. Dis Model Mech 9(4):401–412. https://doi.org/10.1242/dmm.023903
Goudreau JL, Lookingland KJ, Moore KE (1994) 5-Hydroxytryptamine2 receptor-mediated regulation of periventricular-hypophysial dopaminergic neuronal activity and the secretion of alpha-melanocyte-stimulating hormone. J Pharmacol Exp Ther 268(1):175–179
Arai T, Maejima Y, Muroya S, Yada T (2013) Rikkunshito and isoliquiritigenin counteract 5-HT-induced 2C receptor-mediated activation of pro-opiomelanocortin neurons in the hypothalamic arcuate nucleus. Neuropeptides 47(4):225–230. https://doi.org/10.1016/j.npep.2013.05.004
Berglund ED, Liu C, Sohn JW, Liu T, Kim MH, Lee CE, Vianna CR, Williams KW, Xu Y, Elmquist JK (2013) Serotonin 2C receptors in pro-opiomelanocortin neurons regulate energy and glucose homeostasis. J Clin Invest 123(12):5061–5070. https://doi.org/10.1172/JCI70338
Doslikova B, Garfield AS, Shaw J, Evans ML, Burdakov D, Billups B, Heisler LK (2013) 5-HT2C receptor agonist anorectic efficacy potentiated by 5-HT1B receptor agonist coapplication: an effect mediated via increased proportion of pro-opiomelanocortin neurons activated. J Neurosci 33(23):9800–9804. https://doi.org/10.1523/JNEUROSCI.4326-12.2013
Burke LK, Doslikova B, D’Agostino G, Garfield AS, Farooq G, Burdakov D, Low MJ, Rubinstein M, Evans ML, Billups B, Heisler LK (2014) 5-HT obesity medication efficacy via POMC activation is maintained during aging. Endocrinology 155(10):3732–3738. https://doi.org/10.1210/en.2014-1223
Lu D, Willard D, Patel IR, Kadwell S, Overton L, Kost T, Luther M, Chen W, Woychik RP, Wilkison WO et al (1994) Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 371(6500):799–802. https://doi.org/10.1038/371799a0
Makarova EN, Yakovleva TV, Shevchenko AY, Bazhan NM (2010) Pregnancy and lactation have anti-obesity and anti-diabetic effects in A(y)/a mice. Acta Physiol 198(2):169–177. https://doi.org/10.1111/j.1748-1716.2009.02046.x
Derkach KV, Bondareva VM, Chistyakova OV, Berstein LM, Shpakov AO (2015) The effect of long-term intranasal serotonin treatment on metabolic parameters and hormonal signaling in rats with high-fat diet/low-dose streptozotocin-induced type 2 diabetes. Int J Endocrinol. https://doi.org/10.1155/2015/245459
Ebihara K, Ogawa Y, Katsuura G, Numata Y, Masuzaki H, Satoh N, Tamaki M, Yoshioka T, Hayase M, Matsuoka N, Aizawa-Abe M, Yoshimasa Y, Nakao K (1999) Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action. Diabetes 48:2028–2033
Mikhrina AL, Romanova IV (2015) The role of Agrp in regulating dopaminergic neurons in the brain. Neurosci Behav Physiol 45(5):536–541. https://doi.org/10.1007/s11055-015-0107-7
Füzesi T, Wittmann G, Liposits Z, Lechan RM, Fekete C (2007) Contribution of noradrenergic and adrenergic cell groups of the brainstem and agouti-related protein-synthesizing neurons of the arcuate nucleus to neuropeptide-y innervation of corticotropin-releasing hormone neurons in hypothalamic paraventricular nucleus of the rat. Endocrinology 148(11):5442–5450. https://doi.org/10.1210/en.2007-0732
Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3(6):1101–1108
Xu Y, Jones JE, Kohno D, Williams KW, Lee CE, Choi MJ, Anderson JG, Heisler LK, Zigman JM, Lowell BB, Elmquist JK (2008) 5-HT2CRs expressed by pro-opiomelanocortin neurons regulate energy homeostasis. Neuron 60:582–589. https://doi.org/10.1016/j.neuron.2008.09.033
Xu Y, Jones JE, Lauzon DA, Anderson JG, Balthasar N, Heisler LK, Zinn AR, Lowell BB, Elmquist JK (2010) A serotonin and melanocortin circuit mediates d-fenfluramine anorexia. J Neurosci 30:14630–14634. https://doi.org/10.1523/JNEUROSCI.5412-09.2010
Heisler LK, Jobst EE, Sutton GM, Zhou L, Borok E, Thornton-Jones Z, Liu HY, Zigman JM, Balthasar N, Kishi T et al (2006) Serotonin reciprocally regulates melanocortin neurons to modulate food intake. Neuron 51:239–249. https://doi.org/10.1016/j.neuron.2006.06.004
Sohn JW, Xu Y, Jones JE, Wickman K, Williams KW, Elmquist JK (2011) Serotonin 2C receptor activates a distinct population of arcuate pro-opiomelanocortin neurons via TRPC channels. Neuron 71:488–497. https://doi.org/10.1016/j.neuron.2011.06.012
Kim MO, Lee YK, Choi WS, Kim JH, Hwang SK, Lee BJ, Kang SG, Kim K, Baik SH (1997) Prolonged ethanol intake increases D2 dopamine receptor expression in the rat brain. Mol Cells 7(5):682–687
Doron R, Fridman L, Yadid G (2006) Dopamine-2 receptors in the arcuate nucleus modulate cocaine-seeking behavior. Neuroreport 17(15):1633–1636. https://doi.org/10.1097/01.wnr.0000234755.88560.c7
Yoon YR, Baik JH (2015) Melanocortin 4 receptor and dopamine D2 receptor expression in brain areas involved in food intake. Endocrinol Metab (Seoul) 30(4):576–583. https://doi.org/10.3803/EnM.2015.30.4.576
Dubois A, Savasta M, Curet O, Scatton B (1986) Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors. Neuroscience 19(1):125–137
Perreault ML, Shen MY, Fan T, George SR (2015) Regulation of c-fos expression by the dopamine D1-D2 receptor heteromer. Neuroscience 285:194–203. https://doi.org/10.1016/j.neuroscience.2014.11.017
Franco R, Martínez-Pinilla E, Lanciego JL, Navarro G (2016) Basic pharmacological and structural evidence for class A G-protein-coupled receptor heteromerization. Front Pharmacol 7:76. https://doi.org/10.3389/fphar.2016.00076
Miyazaki M, Sampath H, Liu X, Flowers MT, Chu K, Dobrzyn A, Ntambi JM (2009) Stearoyl-CoA desaturase-1 deficiency attenuates obesity and insulin resistance in leptin-resistant obese mice. Biochem Biophys Res Commun 380(4):818–822. https://doi.org/10.1016/j.bbrc.2009.01.183
Madsen AN, Hansen G, Paulsen SJ, Lykkegaard K, Tang-Christensen M, Hansen HS, Levin BE, Larsen PJ, Knudsen LB, Fosgerau K, Vrang N (2010) Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndrome. J Endocrinol 206(3):287–296. https://doi.org/10.1677/JOE-10-0004
Paulsen SJ, Jelsing J, Madsen AN, Hansen G, Lykkegaard K, Larsen LK, Larsen PJ, Levin BE, Vrang N (2010) Characterization of beta-cell mass and insulin resistance in diet-induced obese and diet-resistant rats. Obesity 18(2):266–273. https://doi.org/10.1038/oby.2009.245
Derkach KV, Kuznetsova LA, Chistyakova OV, Ignatieva PA, Shpakov AO (2015) The effect of four-week levothyroxine treatment on hormonal regulation of adenylyl cyclase in the brain and peripheral tissues of obese rats. Biochem Suppl Ser A 9(4):236–245. https://doi.org/10.1134/S1990747815040030
El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, Flier JS (2000) Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 105:1827–1832. https://doi.org/10.1172/JCI9842
Banks WA, Farrell CL (2003) Impaired transport of leptin across the blood-brain barrier in obesity is acquired and reversible. Am J Physiol Endocrinol Metab 285(1):E10–E15. https://doi.org/10.1152/ajpendo.00468.2002
Zhou Y, Rui L (2013) Leptin signaling and leptin resistance. Front Med 7(2):207–222. https://doi.org/10.1007/s11684-013-0263-5
Rowland NE, Schaub JW, Robertson KL, Andreasen A, Haskell-Luevano C (2010) Effect of MTII on food intake and brain c-Fos in melanocortin-3, melanocortin-4, and double MC3 and MC4 receptor knockout mice. Peptides 31(12):2314–2317. https://doi.org/10.1016/j.peptides.2010.08.016
Cakir I, Cyr NE, Perello M, Litvinov BP, Romero A, Stuart RC, Nillni EA (2013) Obesity induces hypothalamic endoplasmic reticulum stress and impairs proopiomelanocortin (POMC) post-translational processing. J Biol Chem 288(24):17675–17688. https://doi.org/10.1074/jbc.M113.475343
Lu XY, Nicholson JR, Akil H, Watson SJ (2001) Time course of short-term and long-term orexigenic effects of Agouti-related protein (86-132). Neuroreport 12:1281–1284
McMinn JE, Wilkinson CW, Havel PJ, Woods SC, Schwartz MW (2000) Effect of intracerebroventricular alpha-MSH on food intake, adiposity, c-Fos induction, and neuropeptide expression. Am J Physiol Regul Integr Comp Physiol 279(2):R695–R703
Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG (2000) Central nervous system control of food intake. Nature 404(6778):661–671. https://doi.org/10.1038/35007534
Cone RD (2005) Anatomy and regulation of the central melanocortin system. Nat Neurosci 8(5):571–578. https://doi.org/10.1038/nn1455
Sindelar DK, Mystkowski P, Marsh DJ, Palmiter RD, Schwartz MW (2002) Attenuation of diabetic hyperphagia in neuropeptide Y-deficient mice. Diabetes 51(3):778–783
Kim JD, Leyva S, Diano S (2014) Hormonal regulation of the hypothalamic melanocortin system. Front Physiol 5:480. https://doi.org/10.3389/fphys.2014.00480
Albarado DC, McClaine J, Stephens JM, Mynatt RL, Ye J, Bannon AW, Richards WG, Butler AA (2004) Impaired coordination of nutrient intake and substrate oxidation in melanocortin-4 receptor knockout mice. Endocrinology 145(1):243–252. https://doi.org/10.1210/en.2003-0452
Zhou L, Sutton GM, Rochford JJ, Semple RK, Lam DD, Oksanen LJ, Thornton-Jones ZD, Clifton PG, Yueh CY, Evans ML et al (2007) Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways. Cell Metab 6:398–405. https://doi.org/10.1016/j.cmet.2007.10.008
Scranton R, Cincotta A (2010) Bromocriptine–unique formulation of a dopamine agonist for the treatment of type 2 diabetes. Expert Opin Pharmacother 11:269–279. https://doi.org/10.1517/14656560903501544
Derkach KV, Ivantsov AO, Sukhov IB, Shpakov AO (2017) Restoration of hypothalamic signaling systems as a cause of improved metabolic parameters in rats with neonatal diabetes model during treatment with bromocryptine mesylate. Cell Tissue Biol 11(3):234–241. https://doi.org/10.1134/S1990519X17030038
Shpakov AO, Derkach KV, Berstein LM (2015) Brain signaling systems in the type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases. Future Sci OA. https://doi.org/10.4155/FSO.15.23
Acknowledgements
This work was supported by the Russian Science Foundation (Project No. 16-15-10388).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Romanova, I.V., Derkach, K.V., Mikhrina, A.L. et al. The Leptin, Dopamine and Serotonin Receptors in Hypothalamic POMC-Neurons of Normal and Obese Rodents. Neurochem Res 43, 821–837 (2018). https://doi.org/10.1007/s11064-018-2485-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-018-2485-z